Skip to main content

Advertisement

Log in

Computed tomography screening for lung cancer

  • Special Edition
  • Diagnosis and Treatment for Early Stage Non-small Cell Lung Cancer
  • Published:
General Thoracic and Cardiovascular Surgery Aims and scope Submit manuscript

Abstract

Cigarette smoking is the attributable cause for 90% of lung cancers. To complement preventative strategies, the advent of lung cancer screening programs targeted at prior and active smokers has been explored to reduce the mortality and morbidity of this lethal malignancy. In this article, we discuss the results of major computed tomography-based lung cancer screening trials, cost-effectiveness of screening, guidelines from major societies and future directions of the field.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003;123(1 Suppl):21S–49S (Review).

    Article  Google Scholar 

  2. Gray N. A global approach to tobacco policy. Lung Cancer. 2003;39(2):113–7.

    Article  Google Scholar 

  3. Detterbeck FC, Boffa DJ, Tanoue LT, et al. The new lung cancer staging system. Chest. 2009;136(1):260–71.

    Article  Google Scholar 

  4. Flehinger BJ, Kimmel M, Polyak T, Melamed MR. Screening for lung cancer. The Mayo Lung Project revisited. Cancer. 1993;72(5):1573–80.

    Article  CAS  Google Scholar 

  5. Frost JK, Ball WC Jr, Levin ML, Tockman MS, Baker RR, Carter D, Eggleston JC, Erozan YS, Gupta PK, Khouri NF, et al. Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis. 1984;130(4):549–54.

    CAS  PubMed  Google Scholar 

  6. Kubík AK, Parkin DM, Zatloukal P. Czech Study on Lung Cancer Screening: post-trial follow-up of lung cancer deaths up to year 15 since enrollment. Cancer. 2000;89(11 Suppl):2363–8.

    Article  Google Scholar 

  7. Kalra MK. Low-dose CT for lung cancer screening. J Am Coll Radiol. 2017;14(5):719–20.

    Article  Google Scholar 

  8. Larke FJ, Kruger RL, Cagnon CH, Flynn MJ, McNitt-Gray MM, Wu X, Judy PF, Cody DD. Estimated radiation dose associated with low-dose chest CT of average-size participants in the National Lung Screening Trial. AJR Am J Roentgenol. 2011;197(5):1165.

    Article  Google Scholar 

  9. Koning HD, Van Der Aalst C, Ten Haaf K, Oudkerk M. Effects of volume CT lung cancer screening: mortality results of the Nelson Randomised-Controlled Population based trial. IASLC 19th World Congress Abstract, September 2018.

  10. Villanti AC, Jiang Y, Abrams DB, et al. A cost-utility analysis of lung cancer screening and the additional benefits of incorporating smoking cessation interventions. PLoS ONE. 2013;8:e71379.

    Article  CAS  Google Scholar 

  11. Pyenson BS, Sander MS, Jiang Y, et al. An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost. Health Aff. 2012;31:770–9.

    Article  Google Scholar 

  12. Goulart BH, Bensink ME, Mummy DG, et al. Lung cancer screening with low-dose computed tomography: costs, national expenditures, and cost-effectiveness. J Natl Compr Canc Netw. 2012;10:267–75.

    Article  Google Scholar 

  13. Mauchley DC, Mitchell JD. Current estimate of costs of lung cancer screening in the United States. Thorac Surg Clin. 2015;25:205–15.

    Article  Google Scholar 

  14. USPSTF website. https://www.uspreventiveservicestaskforce.org/Page/Document/UpdateSummaryFinal/lung-cancer-screening?ds=1&s=lung%20cancer%20screening. Accessed 27 Oct 2019.

  15. Jaklitsch MT, Jacobson FL, Austin JH, Field JK, Jett JR, Keshavjee S, MacMahon H, Mulshine JL, Munden RF, Salgia R, Strauss GM, Swanson SJ, Travis WD, Sugarbaker DJ. The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg. 2012;144(1):33–8.

    Article  Google Scholar 

  16. Wood DE. National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Lung Cancer Screening. Thorac Surg Clin. 2015;25:185–97.

    Article  Google Scholar 

  17. Rampinelli C, De Marco P, Origgi D, Maisonneuve P, Casiraghi M, Veronesi G, Spaggiari L, Bellomi M. Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ. 2017;356:j347.

    Article  Google Scholar 

  18. Sone S, Nakayama T, Honda T, Tsushima K, Li F, Haniuda M, Takahashi Y, Suzuki T, Yamanda T, Kondo R, Hanaoka T, Takayama F, Kubo K, Fushimi H. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography. Lung Cancer. 2007;58(3):329–41.

    Article  Google Scholar 

  19. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012;367(21):1998–2005.

    Article  CAS  Google Scholar 

  20. Ardila D, Kiraly AP, Bharadwaj S, Choi B, Reicher JJ, Peng L, Tse D, Etemadi M, Ye W, Corrado G, Naidich DP, Shetty S. End-to-end lung cancer screening with three-dimensional deep learning on low-dose chest computed tomography. Nat Med. 2019;25(6):954–61.

    Article  CAS  Google Scholar 

  21. Ye K, Zhu Q, Li M, Lu Y, Yuan H. A feasibility study of pulmonary nodule detection by ultralow-dose CT with adaptive statistical iterative reconstruction-V technique. Eur J Radiol. 2019;119:108652.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All other authors have nothing to report with regard to commercial support.

Corresponding author

Correspondence to Monisha Sudarshan.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sudarshan, M., Murthy, S. Computed tomography screening for lung cancer. Gen Thorac Cardiovasc Surg 68, 660–664 (2020). https://doi.org/10.1007/s11748-020-01392-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11748-020-01392-5

Keywords

Navigation